Chongqing Lummy Pharmaceutical Financial Flexibility Index
Chongqing Lummy Pharmaceutical financial flexibility index. Chongqing Lummy Pharmaceutical (300006) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥-4.17 Million (operating CF CN¥-14.90 Million minus capex CN¥10.73 Million) represents 0% of total liabilities (CN¥910.32 Million). See Chongqing Lummy Pharmaceutical free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Chongqing Lummy Pharmaceutical (2006–2024)
Financial flexibility index of Chongqing Lummy Pharmaceutical from 2006 to 2024. Historical Financial Flexibility Index trend for Chongqing Lummy Pharmaceutical across 19 annual periods. Check Chongqing Lummy Pharmaceutical cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Chongqing Lummy Pharmaceutical Financial Flexibility Index by Year (2006–2024)
Chongqing Lummy Pharmaceutical financial flexibility index by year from 2006 to 2024. Year-by-year free cash flow to debt coverage for Chongqing Lummy Pharmaceutical. For the full cash flow conversion analysis, see cash efficiency ratio of Chongqing Lummy Pharmaceutical.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥260.54 Million | CN¥185.03 Million | CN¥972.47 Million | ▲ +46.2% |
| 2023 | 0.18x | CN¥140.85 Million | CN¥81.53 Million | CN¥768.71 Million | ▲ +27.2% |
| 2022 | 0.14x | CN¥125.32 Million | CN¥57.13 Million | CN¥870.02 Million | ▼ -29.9% |
| 2021 | 0.21x | CN¥146.94 Million | CN¥108.28 Million | CN¥714.65 Million | ▲ +46.9% |
| 2020 | 0.14x | CN¥268.12 Million | CN¥224.54 Million | CN¥1.92 Billion | ▼ -12.2% |
| 2019 | 0.16x | CN¥294.37 Million | CN¥231.30 Million | CN¥1.85 Billion | ▼ -35.8% |
| 2018 | 0.25x | CN¥351.82 Million | CN¥225.89 Million | CN¥1.42 Billion | ▲ +205.8% |
| 2017 | 0.08x | CN¥82.62 Million | CN¥61.39 Million | CN¥1.02 Billion | ▼ -67.5% |
| 2016 | 0.25x | CN¥202.63 Million | CN¥125.66 Million | CN¥809.85 Million | ▲ +1087.1% |
| 2015 | 0.02x | CN¥29.78 Million | CN¥-25.41 Million | CN¥1.41 Billion | ▼ -75.3% |
| 2014 | 0.09x | CN¥104.53 Million | CN¥-49.38 Million | CN¥1.23 Billion | ▼ -79.1% |
| 2013 | 0.41x | CN¥430.10 Million | CN¥74.70 Million | CN¥1.06 Billion | ▲ +48.5% |
| 2012 | 0.27x | CN¥195.51 Million | CN¥18.18 Million | CN¥713.21 Million | ▼ -21.5% |
| 2011 | 0.35x | CN¥146.95 Million | CN¥11.85 Million | CN¥420.81 Million | ▼ -17.6% |
| 2010 | 0.42x | CN¥136.63 Million | CN¥37.66 Million | CN¥322.42 Million | ▼ -2.9% |
| 2009 | 0.44x | CN¥56.09 Million | CN¥37.35 Million | CN¥128.55 Million | ▲ +34.7% |
| 2008 | 0.32x | CN¥42.35 Million | CN¥17.25 Million | CN¥130.77 Million | ▼ -13.8% |
| 2007 | 0.38x | CN¥40.12 Million | CN¥21.68 Million | CN¥106.78 Million | ▼ -2.1% |
| 2006 | 0.38x | CN¥23.30 Million | CN¥7.77 Million | CN¥60.72 Million | — |